ABBV announced that the FDA has accepted its supplemental biologics license application (sBLA) seeking approval of its blockbuster product, Botox, for a new indication. The company is looking to get …
( read original story …)
The SkinCare Site
ABBV announced that the FDA has accepted its supplemental biologics license application (sBLA) seeking approval of its blockbuster product, Botox, for a new indication. The company is looking to get …
( read original story …)